FindTrial
Sign In

The role and Mechanism of Hepcidin on the Development of Neonatal Necrotizing Enterocolitis

The role and Mechanism of Hepcidin on the Development of Neonatal Necrotizing Enterocolitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016664
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-06-20
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The role and Mechanism of Hepcidin on the Development of Neonatal Necrotizing Enterocolitis

Interventions

Neonatal Necrotizing Enterocolitis:Peripheral blood

Sponsors

Children's Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Neonates to have the sugery for NEC in my hospital

Exclusion criteria

Exclusion criteria: Whoever refuse to attend the research.

Design outcomes

Primary

MeasureTime frame
Hepcidin;—

Countries

China

Contacts

Public ContactHu Yaoqin

Children's Hospital, Zhejiang University school of Medicine

huyaoqin@sina.com+86 15167112579

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026